PCPaula Colmenero

Paula Colmenero

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Paula Colmenero has a total of 31 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew Filer

    Research into Inflammatory Arthritis Centre Versus Arthritis (RACE), UK; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre and NIHR Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Rheumatology Research Group, School of Infection, Inflammation and Immunology, University of Birmingham, Birmingham, UK; Birmingham Tissue Analytics, Institute of Translational Medicine, University of Birmingham, Birmingham, UK

    1 shared publication
  • April Pawluk

    Arc Institute, Palo Alto, USA

    1 shared publication
  • Arthur G. Pratt

    Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK

    1 shared publication
  • Brian D. Marsden

    Centre for Human Genetics and Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford

    1 shared publication
  • Caroline Moussa

    Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedic, Rheumatology and Musculoskeletal Sciences, Oxford University, Oxford OX3 7FY, UK

    1 shared publication
  • Claire Pearson

    Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK

    1 shared publication

Latest Publications

  • Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes

    by Kelsey N. Thompson, Kevin S. Bonham, Nicholas E. Ilott, Graham J. Britton, Paula Colmenero, Samuel J. Bullers, Lauren J. McIver, Siyuan Ma, Long H. Nguyen, Andrew Filer, et al.

    Musculoskeletal diseases affect up to 20% of adults worldwide. The gut microbiome has been implicated in inflammatory conditions, but large-scale metagenomic evaluations have not yet traced the routes by which immunity in the gut affects inflammatory arthritis. To characterize the community structure and associated functional processes driving gut microbial involvement in arthritis, the Inflammatory Arthritis Microbiome Consortium investigated 440 stool shotgun metagenomes comprising 221 adults diagnosed with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis and 219 healthy controls and individuals with joint pain without an underlying inflammatory cause. Diagnosis explained about 2% of gut taxonomic variability, which is comparable in magnitude to inflammatory bowel disease. We identified several candidate microbes with differential carriage patterns in patients with elevated blood markers for inflammation. Our results confirm and extend previous findings of increased carriage of typically oral and inflammatory taxa and decreased abundance and prevalence of typical gut clades, indicating that distal inflammatory conditions, as well as local conditions, correspond to alterations to the gut microbial composition. We identified several differentially encoded pathways in the gut microbiome of patients with inflammatory arthritis, including changes in vitamin B salvage and biosynthesis and enrichment of iron sequestration. Although several of these changes characteristic of inflammation could have causal roles, we hypothesize that they are mainly positive feedback responses to changes in host physiology and immune homeostasis. By connecting taxonomic alternations to functional alterations, this work expands our understanding of the shifts in the gut ecosystem that occur in response to systemic inflammation during arthritis.